IMUX Immunic, Inc.
$7.28▼ -1.75%
Healthcare
Other
Volume 432.3K
Avg Volume (10D) 373.4K
Key Metrics & Fundamentals
Market Cap
$99.33M
P/E Ratio
–
Div Yield
0.00%
52W Range
5.06 - 17.43
% vs 50 MA
-33.46%
% vs 200 MA
-36.56%
RSI-14
35.3
MACD Histogram
+0.2000
Beta (1Y vs SPY)
1.54
Free Cash Flow
-$31.25M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$35.29M
COGS
–
Operating Exp
$35.33M
Operating Income
-$35.33M
EBIT
-$35.33M
Pretax Income
-$34.10M
Net Income
-$34.10M
EPS (Diluted)
-0.80
Price & Volume History
Loading chart…
Recent News
New Strong Buy Stocks for October 22nd
Zacks · Oct 22, 2026 4:07 AM ET
Immunic Presents New Clinical, Biomarker, and Preclinical Data for Vidofludimus Calcium in Four Poster Presentations at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
PR Newswire · Oct 21, 2026 7:00 AM ET
Immunic adds new Chief People Officer ahead of Phase 3 readout
Proactive · Oct 19, 2026 8:27 AM ET
Immunic Appoints Jaa Roberson as Chief People Officer
PR Newswire · Oct 19, 2026 6:30 AM ET
Immunic to present four vidofludimus calcium abstracts at MSToronto2026
Proactive · Oct 7, 2026 11:04 AM ET
Immunic to Present New Clinical, Biomarker and Preclinical Data on Vidofludimus Calcium at MSToronto2026 - the 10th Joint ACTRIMS-ECTRIMS Meeting
PR Newswire · Oct 7, 2026 8:00 AM ET
Immunic to host virtual relapsing MS R&D Day on September 9
Proactive · Sep 2, 2026 8:40 AM ET
Immunic to Host Virtual Relapsing Multiple Sclerosis R&D Day on September 9, 2026
PR Newswire · Sep 2, 2026 6:30 AM ET
Immunic appoints Chitrang Davé as chief data and digital officer
Proactive · Sep 1, 2026 8:36 AM ET
Financial Overview - Income Statement
Quarterly
No financial data available. Click Refresh on the ticker to load latest fundamentals.
See IMUX's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.